PAHCPhibro Animal Health Corporation
Price
-3.0%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality mixed, nothing alarming, price roughly fair, growing in the filings, the market undecided.
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. We market approximately 800 product lines in approximately 90 countries to approximately 4,500 customers.
In the company’s own words · 10-K filed Aug 27, 2025 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Phibro Animal Health Corporation (PAHC) reported revenue of $397M in Q4 2026 (quarter ended Jun 30, 2026), up 4.8% from the same quarter a year earlier. That came with a gross margin of 34% and net income of $22M (5.5% of revenue). For the full year FY2026, revenue was $1.52B (+17% year on year) and net income $100M. Its largest product in Q4 2026 was Medicated Feed Additives And Others at $208M, 52% of the disclosed total, well ahead of Mineral Nutrition at 19%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 26, 2026Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance.Earnings release · press release
- Jul 28, 2026On July 28, 2026, Phibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 23, 2026, to stockholders of record at the close of business on September 2, 2026.Other event · Form 8-K
- Jun 26, 2026On June 25, 2026, in connection with Daniel (Dani) Bendheim’s appointment to the role of Chief Executive Officer and President of the Company effective July 1, 2026 (the “Effective Date”), the Compensation Committee of the Board of Directors of Phibro Animal Health Corporation (the “Company”) approved (i) the …Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $396.7MThe company’s own SEC segment disclosure.
- Medicated Feed Additives And Others$207.6M52%
- Mineral Nutrition$77.0M19%
- Nutritional Specialties$49.9M13%
- Vaccines$40.0M10%
- Performance Products$22.2M6%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Drug Manufacturers, Specialty & Generic
Ranks #8 of 41 by RyuScore